Literature DB >> 10456203

Screening for aetiology of thrombophilia: a high prevalence of protein S abnormality.

H Tsuda1, S Hattori, S Tanabe, H Iida, M Nakahara, S Nishioka, M Fujise, S Kinoshita, K Okubo, N Hamasaki.   

Abstract

We systematically screened for the aetiology of thrombophilia in 115 patients with venous, arterial and small vessel thromboses. Forty-one patients (36% of those we examined) suffering from a variety of thromboses, including deep vein thrombosis, pulmonary embolism, arterial occlusion, cerebral infarction, Moyamoya disease and ulcerative colitis, were characterized either with positive lupus anticoagulants or with decreased activities of protein S, protein C, antithrombin III and/or plasminogen. Eight mutation sites were confirmed in 11 thrombotic patients using gene analysis. Decreased protein S activity was found with a high incidence (23 out of 115) in Japanese patients who suffered from not only venous thrombosis but also arterial and small vessel thrombosis. We emphasize here the important role of protein S in the pathogenesis of thrombosis in the Japanese population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456203     DOI: 10.1177/000456329903600404

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  8 in total

1.  Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.

Authors:  Masaya Hirose; Fuminori Kimura; Hua-Qin Wang; Koichi Takebayashi; Masashi Kobayashi; Keiko Nakanishi; Minoru Akiyama; Toshio Kimura; Yoichi Noda
Journal:  J Thromb Thrombolysis       Date:  2002-04       Impact factor: 2.300

2.  Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum.

Authors:  Reiko Neki; Tomio Fujita; Koichi Kokame; Isao Nakanishi; Masako Waguri; Yuzo Imayoshi; Noriyuki Suehara; Tomoaki Ikeda; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2011-08-03       Impact factor: 2.490

3.  The association of protein S Tokushima-K196E with a risk of deep vein thrombosis.

Authors:  Makoto Ikejiri; Hideo Wada; Yuko Sakamoto; Naohiko Ito; Junji Nishioka; Kaname Nakatani; Akihiro Tsuji; Norikazu Yamada; Mashio Nakamura; Masaaki Ito; Tsutomu Nobori
Journal:  Int J Hematol       Date:  2010-09-02       Impact factor: 2.490

4.  Age-specific onset and distribution of the natural anticoagulant deficiency in pediatric thromboembolism.

Authors:  Masako Ichiyama; Shouichi Ohga; Masayuki Ochiai; Koichi Tanaka; Yuka Matsunaga; Takeshi Kusuda; Hirosuke Inoue; Masataka Ishimura; Tomohito Takimoto; Yui Koga; Taeko Hotta; Dongchon Kang; Toshiro Hara
Journal:  Pediatr Res       Date:  2015-09-15       Impact factor: 3.756

5.  Moyamoya-like vasculopathy (moyamoya syndrome) in children.

Authors:  Peter Horn; Stefan Pfister; Eva Bueltmann; Peter Vajkoczy; Peter Schmiedek
Journal:  Childs Nerv Syst       Date:  2004-05-01       Impact factor: 1.475

Review 6.  Genotypic and phenotypic character of Chinese neonates with congenital protein C deficiency: a case report and literature review.

Authors:  Xiaoying Li; Xiaoyan Li; Xiao Li; Yuanhua Zhuang; Lili Kang; Xiuli Ju
Journal:  Thromb J       Date:  2019-10-02

7.  Reduced Activity of Protein S in Plasma: A Risk Factor for Venous Thromboembolism in the Japanese Population.

Authors:  Xiuri Jin; Sachiko Kinoshita; Hiroyuki Kuma; Tomohide Tsuda; Tatsusada Yoshida; Dongchon Kang; Naotaka Hamasaki
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 8.  Activated protein C anticoagulant system dysfunction and thrombophilia in Asia.

Authors:  Naotaka Hamasaki; Hiroyuki Kuma; Hiroko Tsuda
Journal:  Ann Lab Med       Date:  2012-12-17       Impact factor: 3.464

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.